Does RADIUM RA-223 DICHLORIDE Cause Urinary retention? 26 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Urinary retention have been filed in association with RADIUM RA-223 DICHLORIDE (Xofigo). This represents 0.5% of all adverse event reports for RADIUM RA-223 DICHLORIDE.
26
Reports of Urinary retention with RADIUM RA-223 DICHLORIDE
0.5%
of all RADIUM RA-223 DICHLORIDE reports
6
Deaths
17
Hospitalizations
How Dangerous Is Urinary retention From RADIUM RA-223 DICHLORIDE?
Of the 26 reports, 6 (23.1%) resulted in death, 17 (65.4%) required hospitalization.
Is Urinary retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RADIUM RA-223 DICHLORIDE. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does RADIUM RA-223 DICHLORIDE Cause?
Prostatic specific antigen increased (449)
Hormone-refractory prostate cancer (441)
Death (376)
Anaemia (324)
Metastases to bone (315)
General physical health deterioration (308)
Fatigue (242)
Haemoglobin decreased (236)
Prostate cancer (234)
Nausea (221)
What Other Drugs Cause Urinary retention?
MIRABEGRON (706)
QUETIAPINE (617)
TAMSULOSIN (475)
ADALIMUMAB (452)
MORPHINE (407)
OLANZAPINE (405)
SERTRALINE (380)
PREGABALIN (376)
RISPERIDONE (375)
DULOXETINE (362)
Which RADIUM RA-223 DICHLORIDE Alternatives Have Lower Urinary retention Risk?
RADIUM RA-223 DICHLORIDE vs RALOXIFENE
RADIUM RA-223 DICHLORIDE vs RALTEGRAVIR
RADIUM RA-223 DICHLORIDE vs RALTITREXED
RADIUM RA-223 DICHLORIDE vs RAMELTEON
RADIUM RA-223 DICHLORIDE vs RAMIPRIL